Your search returned 3 results.

Results
	1.	BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib. [electronic resource] by Byrgazov, Konstantin Lucini, Chantal Blanche Valent, Peter Hantschel, Oliver Lion, Thomas Producer: 20190724 In: Haematologica vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors. [electronic resource] by Byrgazov, Konstantin Lucini, Chantal Blanche Berkowitsch, Bettina Koenig, Margit Haas, Oskar A Hoermann, Gregor Valent, Peter Lion, Thomas Producer: 20180320 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1 [electronic resource] by Schneeweiss-Gleixner, Mathias Byrgazov, Konstantin Stefanzl, Gabriele Berger, Daniela Eisenwort, Gregor Lucini, Chantal Blanche Herndlhofer, Susanne Preuner, Sandra Obrova, Klara Pusic, Petra Witzeneder, Nadine Greiner, Georg Hoermann, Gregor Sperr, Wolfgang R Lion, Thomas Deininger, Michael Valent, Peter Gleixner, Karoline V Producer: 20200430 In: EBioMedicine vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search